Johnson & Johnson, in conjunction with its DePuy Orthopaedics subsidiary, announced a major recall for hip implants after it was discovered the implants loosened, causing pain and requiring replacement. At issue is the high rate of repeat total hip replacement (THR) surgeries needed by people who have received the parts. An estimated 93,000 people will be affected by Johnson & Johnson's latest product recall.

Affected hip replacement parts involved in the recall include the DePuy ASR XL Acetabular System, which is the cup portion of a replacement hip joint, and the DePuy ASR Hip Resurfacing System. The high failure rate has been attributed to the design of the hip components. Small pieces of metal are released into surrounding tissue, preventing the device from bonding firmly with natural bone. Individuals with this device still in them will need to be monitored closely and ultimately may need hip revision surgery.

If you click on the image to the left, you'll find a patient treatment flow chart created by DePuy Orthopaedics as directed by the Medicines and Healthcare Products Regulatory Agency. This information was also provided to orthopaeidc surgeons who had performed THR sugeries.

By publishing this chart, Pitman, Kyle, Sicula & Dentice is not providing medical advice. If you've had a THR, please consult your orthopaedic surgeon.

Although this recall is voluntary, DePuy also received a warning letter from the FDA that charges the company is marketing some other joint replacement products without required approval.

Patients who reported problems in the first five years and had revision surgery reported a variety of symptoms, including pain, swelling and problems walking. These symptoms are normal for patients following a hip replacement, but can be a sign that something is wrong if they continue or come back frequently. These symptoms may indicate serious problems, including: